https://www.thebodypro.com/category/hiv-treatment-as-prevention
HIV Prevention Methods

U=U (Undetectable Equals Untransmittable, i.e. HIV Treatment as Prevention)

The Latest

crowd
News

This Week in HIV Research: A Question of Turnout

May 20, 2021: HIV testing and prevalence trends in the U.S.; groups at higher risk for losing viral suppression; intent vs. reality in making clinic appointments; transitioning from pediatric to adult HIV care.

By Barbara Jungwirth and Myles Helfand
invisible ink
News

This Week in HIV Research: Missing the Message

May 13, 2021: Disparities in U=U awareness; sexual satisfaction trends among PLWH; PrEP use among cis women; HCV epidemiology in trans women.

By Barbara Jungwirth and Myles Helfand
American teens
News

This Week in HIV Research: We Need to Better Serve Our Teens

April 8, 2021: PrEP “contemplation” and uptake among adolescents; adolescent perception of HIV risk; HIV diagnosis rates among transgender people; PrEP and HIV incidence in Scotland.

By Barbara Jungwirth and Myles Helfand
Hippocratic oath
News

This Week in HIV Research: U=U and the Hippocratic Oath

April 1, 2021: The ethics of teaching U=U; the role of primary care in HIV service acceptance; STI testing rates in transgender women; the potential in anal self-sampling.

By Barbara Jungwirth and Myles Helfand
doctor patient hands
News

This Week in HIV Research: Health in Unity

Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.

By Barbara Jungwirth and Myles Helfand
intimate
Interviews

Understanding U=U Can Improve Health Outcomes for People Living with HIV—but the Message Matters

W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.

By Terri Wilder, M.S.W.
COVID-19 mask profile
News

This Week in HIV Research: The Real-World Effects of COVID-19

Oct. 22, 2020: Impact of COVID-19 shutdowns on HIV viral suppression; unsuppressed HIV viral load despite no treatment failure; point-of-care rapid testing vs. lab testing; it's not about "what," it's about "when."

By Barbara Jungwirth and Myles Helfand
MSM
News

This Week in HIV Research: Incidence and Clinical Care Trends Among MSM

Oct. 1, 2020: HIV surveillance trends among U.S. MSM; health insurance and viral suppression; PrEP prescribing among motivated clinicians; PrEP sharing between MSM.

By Barbara Jungwirth and Myles Helfand
Juan Berenguer, M.D., Ph.D. and Antonio Urbina, M.D.
Interviews

Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM

Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.

By Terri Wilder, M.S.W. and Myles Helfand
brain dissipation
News

This Week in HIV Research: What We Don’t Know Hurts Them

Aug. 20, 2020: HIV knowledge and stigma among health care workers in the southern U.S.; condomless sex vs. HIV risk among MSM; how drug class choice may affect onward transmission risk; STI screening rates among MSM on PrEP.

By Barbara Jungwirth and Myles Helfand